Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from gene editing

Genie out of the bottle on gene editing

No longer the stuff of science fiction, gene editing must be used in a safe and ethical way, writes Dr Hilary Sheppard.

Newsroom.co.nz

Hybrid tree wrongly sold as 'sterile' highlights potential wildings solution

A hybrid pine variety in huge demand has been labelled sterile and unable to spread without any evidence to support the claim.

Newsroom.co.nz

Scotland should embrace UK moves on gene-editing science, says Alister Jack

ALISTER Jack has used a visit to a farming tech centre to reiterate calls for Scotland to embrace controversial gene-editing science – despite…

The National (Scotland)

From analysis to the latest developments in health,
read the most diverse news in one place.

Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis

Intellia Therapeutics Inc (NASDAQ:NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced additional interim data from the Phase 1 study of NTLA-2001, in vivo genome editing candidate for transthyretin (ATTR) amyloidosis. Intellia had said that at the highest dose level (1.0mg/kg), six patients had shown a 93% mean reduction in the toxic protein. In the new data,…

Benzinga

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

BMO Capital Sees Over 400% Upside For This Small Gene-Editing Stock

BMO Capital Markets initiated coverage on Graphite Bio Inc (NASDAQ:GRPH), with a price target of $12 and an Outperform rating. The analyst notes that Graphite's gene editing approach involves a DNA repair mechanism that is known to be less vulnerable to errors. BMO writes that Graphite's platform is expected to be safer than existing…

Benzinga

Gene-editing bill should not ‘force products on Scotland’, says minister

A BILL that would ease regulations around gene editing in the food sector should not “force products on Scotland”, a minister has said.

The National (Scotland)

Read news from The Economist, FT, and more,
with one subscription

Food experts slam BBC for 'repeating Tory lies’ on genetic edited foods

THE BBC and other media have been accused of “repeating uncritically and ad nauseam” UK Government “lies” about genetically edited foods.

The National (Scotland)

Britain is paving the way for gene-edited food – will the public stomach it?

Twenty years ago, the anti-GM movement had wide backing. Experts say the current mood on gene editing is softer

The Guardian - UK

Gene editing could increase food security, UK adviser says

Legislation introduced in House of Lords aims to help speed up development of gene-edited products

The Guardian - UK

Britain Finally Relaxes GMO Rules, but Advocates Want More Deregulation

New GMO rules are a good break from the E.U., but they don't go far enough.

Reason

Queen’s Speech: Gene editing of animals and plants to get green light

Bill to relax regulations part of plan to ditch EU rules after Brexit

The Independent UK

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Regeneron Pharmaceuticals Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.